Meade T W, Howarth D J, Brennan P J
MEC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, Medical College of St Bartholomew's Hospital, London, UK.
Thromb Haemost. 1994 Mar;71(3):284-5.
The effects on the haemoglobin level of low dose aspirin and of low intensity oral anticoagulation with warfarin separately and in combination have been established in men aged between 45 and 69 at high risk of ischaemic heart disease. The findings confirm that combined treatment with warfarin and aspirin (WA) leads to a clear excess of minor bleeding episodes over warfarin alone (W) or aspirin alone (A). Each separate treatment on its own (either W or A) leads to an increase in these episodes compared with those on placebo (P) treatment. However, neither combined treatment (WA) nor the separate treatments (W or A) cause a fall in haemoglobin levels over a period of up to two years.
低剂量阿司匹林、低强度口服华法林抗凝单独及联合应用对年龄在45至69岁之间、患缺血性心脏病风险较高的男性血红蛋白水平的影响已得到证实。研究结果证实,与单独使用华法林(W)或单独使用阿司匹林(A)相比,华法林与阿司匹林联合治疗(WA)导致轻微出血事件明显增多。与安慰剂(P)治疗相比,每种单独治疗(W或A)都会使这些事件增加。然而,在长达两年的时间内,联合治疗(WA)和单独治疗(W或A)均未导致血红蛋白水平下降。